Profiles of top US healthcare investors

Published by: mike 2009-01-08

Who are the top US healthcare investors among Venture Capitalists, Private Equity Firms, or other Investment Firms of Healthcare and Medical Devices in particular? I'm looking for profiles of the top 5-10 investors to understand their investment philosophy, focus, total investment $, clinical area focus, regional interests.

Hello again Jimwalden, Below you will find the results of my research for this question. 2005 venture capital investments into biotech went up 5% from 2004 to $7.3 bln. ?MPM Capital led the top 10 venture firms by number of investments during 2005, having participated in 17 investments, followed by Alta Partners, Domain Associates and HealthCap, each with 15 investments? ZDNet Research http://blogs.zdnet.com/ITFacts/?p=9909 ==================================== Healthcare Corporate Finance News announces that health care venture capital funding reaches highest level in three years. ?During the year ended December 31, 2005, the size of the health care venture capital market grew to nearly $7.3 billion invested.? ?Compared with 2004, the amount of total dollars invested increased by more than 5%.? ?The total number of health care venture capital deals increased by 11% in 2005, compared with 2004.? Sector Venture Capital Deals Biopharmaceuticals $2.1 billion 102 Medical Devices $1.4 billion 97 Pharmaceuticals $1.4 billion 70 Biotechnology $1.3 billion 86 Health Care Venture Capital Deal and Dollar Volume Year Number of Deals Total Funding, in Billions 2003 386 $5.5 2004 399 $6.9 2005 443 $7.3 ------------------------------- Top 10 Venture Capital Firms, By Participation in Number of Health Care Investments ------------------------------- QUARTER ended December 31, 2005 ------------------------------- Firm Investments ------------------------------- 3i 5 Abingworth 5 Alta Partners 4 Canaan Partners 4 CDIB 4 InterWest Partners 4 MPM Capital 4 ProQuest Investments 4 Venrock Associates 4 HBM funds 4 ------------------------------- ------------------------------- Top 10 Venture Capital Firms, By Participation in Number of Health Care Investments ------------------------------- YEAR ended December 31, 2005 ------------------------------- Firm Investments ------------------------------- MPM Capital 17 Alta 15 Domain 15 HealthCap 15 3i 11 HBM funds 11 Montreux 11 SV Life Sciences 11 Abingworth 10 Frazier Healthcare 10 Yahoo Finance: January 2006 http://biz.yahoo.com/prnews/060112/nyth100.html?.v=38 ==================================== At the link below you will find informative profiles for over 80 Venture Capital Firms Active in the Medical Device Field http://www.devicelink.com/links/venture.html Some examples: MPM Capital ?MPM Capital is the manager for the $230 million BioVentures family of venture capital funds that are invested in parallel in selected private healthcare companies in the US and Europe. BB Bioventures LP investments range from $5 million to $20 million. The current portfolio includes manufacturers of surgical sealants, diabetes management systems, hearing aids, and transdermal drug-delivery systems.? Alta Partners ?Alta Partners prefers to act as the lead investor, taking a board seat, and assisting the company as it develops. Typically, between $2 million and $8 million is invested in a company throughout the life of the investment. Focus is on the West Coast.? Domain Associates ?Domain Associates provides $30 million to $40 million annually to US-based ventures concentrating in the life sciences. Current portfolio includes some well-known device firms, including developers of tumor-ablation devices, wearable defibrillators, minimally invasive surgical instruments, and surgical vision systems.? See complete list and profiles here: http://www.devicelink.com/links/venture.html =================================== Company Profiles - 2005 Top 10 List =================================== ----------- MPM Capital ----------- ?MPM Capital is the world's largest dedicated investor in life sciences. With committed capital under active management of more than $2 billion, MPM Capito is uniquely structured to invest globally in healthcare innovation.? http://www.mpmcapital.com/flash/home.html MPM Investments in Biotechnology and Biopharmaceuticals http://www.mpmcapital.com/flash/portfolio/biotech.html MPM Investments in Medical Technology http://www.mpmcapital.com/flash/portfolio/medtech.html Company Financings http://www.mpmcapital.com/flash/news/co_news/financings.html ------------- Alta Partners ------------- ?Alta Partners currently manages seven venture fund programs aggregating approximately $1.5 billion in committed capital.? http://www.altapartners.com/ ?Alta Partners is a venture capital firm founded in 1996, currently managing seven venture fund programs aggregating approximately $1.5 billion in committed capital. Alta has funded approximately 130 life sciences and information technology companies to date. The firm invests in both early and later stage companies, through separate stage-specific funds. Alta Partners is a successor to Burr, Egan, Deleage & Co., which was founded in 1979.? http://www.altapartners.com/about.html Portfolio: - Biotechnology and Biopharmaceutical companies - Medical Technology and Health Care Companies A brief description is given for each one. http://www.altapartners.com/lifesciences.html News http://www.altapartners.com/news.html ----------------- Domain Associates ----------------- History ?Founded in 1985 to invest exclusively in emerging life sciences companies? Portfolio ?Involved in formation of more than 170 companies over last 20 years.? Assets ?$1.4 billion capital under management? Locations ?Offices in Princeton, NJ and Laguna Niguel, CA? http://www.domainvc.com/ ?Domain?s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics.? Domain?s investment activity can be grouped into three categories: Venture Investing Public Market Investing Company Formation http://www.domainvc.com/about.asp Portfolio Companies (By Industry) http://www.domainvc.com/Portfolio_Industry.asp Active Portfolio companies http://www.domainvc.com/Portfolio.asp?Filter=A --------- HealthCap --------- ?HealthCap is a family of multi stage venture capital funds, investing internationally in life sciences, with the Odlander Fredrikson Group as their exclusive investments advisor. With committed capital exceeding MSEK 6,300 HealthCap is the largest specialized provider of venture capital within life sciences in the Nordic countries and one of the largest independent actors in the sector in Europe.? http://www.healthcap.se/ ?They invest globally in pharmaceutical, biotechnology and medical technology companies. Investments are made in early stage opportunities as well as in more mature companies.? ?The three first funds have financed 55 companies. Approximately 20 of the companies were start-ups and several have successfully completed their Initial Public Offerings. HealthCap I, II and III are now fully invested.? http://www.healthcap.se/default.asp?page=docs/funds.asp The Investments See portfolio and brief description here: http://www.healthcap.se/default.asp?page=docs/investments_frame.asp -- 3i -- 3i is a world leader in private equity and venture capital. From early-stage venture capital to growth capital and buyouts, they ?invest ?1.3bn a year in some of the most exciting and ambitious companies in the world.? http://www.3i.com/ 3i has a substantial portfolio spanning three continents. To find out more about the companies that 3i has partnered with to deliver success, please use the search facility below. http://www.3i.com/ourportfolio/index.html News http://www.3i.com/media/index.html --- HBM --- ?HBM BioVentures is a leading holding company in the human medicine, biotech and medical technology industries. It enables investors to tap in to a broadly diversified portfolio of private and primarily small-cap public companies with high value creation potential in an investment segment that is difficult to access. HBM BioVentures is recognised as a complement to traditional pharmaceutical and biotech investments. HBM BioVentures is an active investor which finances, supports and shapes portfolio companies as a key partner.? ?HBM BioVentures focuses on companies with convincing product pipelines and high value creation potential. The portfolio encompasses both private and smaller public companies. HBM BioVentures invests in attractively valued companies and, in some instances, assumes strategic entrepreneurial responsibility. HBM BioVentures holds over 50 positions and aims to significantly increase its investment volume.? http://www.hbmbioventures.com/index_en.php Portfolio http://www.hbmbioventures.com/menu/indexen2.php Financial Reports http://www.hbmbioventures.com/menu/indexen3.php -------- Montreux -------- ?Montreux is focused on investments in life science & healthcare companies that target attractive market opportunities in the pharmaceutical/biopharmaceutical, medical device, healthcare services and life sciences industries.? http://www.montreuxequity.com/sec/strategy ?Founded in 1993, Montreux Equity Partners, based in Menlo Park, CA, is a private equity firm that invests in new and emerging life science and healthcare companies. Montreux also selectively invests in "special situations" companies. Montreux?s goal is to generate long-term capital gains for both our investors and the entrepreneurs that we support. Montreux has over $190 million under management and is currently investing out of funds with over $170 million in capital. Montreux investment ranges from $2-$5 million in any given financing and up to $12 million over the life cycle of the investment. We invest at all stages of the company life cycle, investing in early, intermediate and later stage private companies.? http://www.montreuxequity.com/sec/about Portfolio Companies http://www.montreuxequity.com/sec/portfolio ---------------- SV Life Sciences ---------------- ILSF funds and IBT concentrate on investments within the United States and Western Europe but will consider investments in other countries where there is a well-developed life sciences sector. ILSF funds typically invests in equity or near equity securities of private companies, or, on occasion, small public companies. The focus is to take a lead investor position in a small, strong investment syndicates. http://www.svlsa.com/pages/investment_criteria1.htm ?SVLS advised or managed funds invest in companies requiring funding within the human life sciences sector including biotechnology and pharmaceuticals, medical devices and instruments, healthcare IT and services.? ?SVLS was established in 1993 and currently has offices in Boston, London and San Francisco.? ?SVLS advises or manages four funds with total capital of approximately $900m which invest in life science companies at all stages of development. SVLS has 25 professionals who are able to provide hands on scientific, advisory and financial support to their portfolio companies.? ?Three of the funds are venture capital limited partnerships which provide seed, start-up, early stage and expansion capital primarily to private companies in North America and Europe. The most recently raised fund, SV Life Sciences Fund III (ILSF III), closed on 30 May 2003 with total commitments of $402m. Typical investment size for these funds is between $2m and $20m.? ?The fourth fund International Biotechnology Trust plc is a publicly quoted investment trust listed on the London Stock Exchange (ticker IBT), with total net asset value of approximately $99m ( 56m as at 1 October 2005). IBT has an investment focus on later stage private and smaller cap listed life sciences stocks and typical investment size is $1 to $4m.? http://www.svlsa.com/index.htm Investments http://www.svlsa.com/pages/investments.htm ---------- Abingworth ---------- ?Abingworth is a long-established venture capital firm specialising in unquoted and life science biomedical companies. With offices in London, Cambridge (UK), Menlo Park and Boston, Abingworth is active on both sides of the Atlantic and, in the past fifteen years, has backed more than 80 developing life science/medical businesses. The majority of these have gone on to public offerings or have merged or been acquired by leading companies in the industry. Abingworth has funds under management of over $700 million.? http://www.abingworth.com/ ?Abingworth's investments generally range between $1-20 million averaging around $15 million per investment after all rounds of private financing. Abingworth can also put together a syndicate of investors to raise up to $50 million.? http://www.abingworth.com/invest.htm Portfolio Companies http://www.abingworth.com/portfolio.jsp?ref=1 Company News http://www.abingworth.com/news.jsp ------------------ Frazier Healthcare ------------------ ?- Formed in 1991 to invest exclusively in emerging healthcare companies - Biopharma, Medical Devices and Healthcare Services - Building innovative healthcare companies while providing high returns - Over 85 companies funded; 21 public; 14 acquired - Over $1.2 billion of capital under management? http://www.frazierhealthcare.com/ Portfolio - Biopharma - Medical Devices - Healthcare Services http://www.frazierhealthcare.com/portfolio/index.asp Recent Financings http://www.frazierhealthcare.com/news/recentfinancings.asp ============================================ Additional Information that may interest you ============================================ Venture Capital Investment in Health Industries Report 2005 - Q3 ?Venture capital investment in the life sciences and health related industries has stablized at approximately $1.5 for the past ten quarters. This quarterly report summarizes investment activity in the health related industries for Q3 2005 and provides detailed analysis on a sub-sector basis." The Venture Capital Investment in Health Industries Report is a comprehensive analysis of venture capital investments specifically within the health industries. The report uses survey data from the MoneyTree Survey, released by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association. You will find a wealth of statistics, graphs and pie charts in this report. http://www.pwcglobal.com/extweb/pwcpublications.nsf/docid/027CAA5EE6C25E90852570D200787D11 A full copy of the report is available for download at http://healthcare.pwc.com/cgi-local/hcregister.cgi?link=reg/mt2005q3.pdf FREE Registration is required For example: Page 6 - Health Industries Venture Capital Report Company Investments by Sector Page 7 - Medical Devices and Equipment Page 10-19 shows the following data for the different health industry sectors: Investors Investee Company Financing Amount Raised ($) Nature of Business ==================================== Download the previous report as well. Venture Capital Investment in Health Industries Full Year and Q4 2004 Results Download here: http://www.pwcmoneytree.com/exhibits/Health_Industries_Report_Q4-Full_Year_2004.pdf ==================================== Equity by Industry Equity Financings* for US Venture-Backed Companies, by Industry Group (1997-4Q' 2003) *Equity financings include cash investments by professional venture capital firms, corporations, other private equity firms, and individuals into companies that have received at least one round of venture funding Data is supplied for the following segments of the healthcare industry group: - Biopharmaceuticals - Healthcare Services - Medical Devices - Medical Information Systems Download Excel Spreadsheet here: Venture One http://www.ventureone.com/ii/4Q03_Financing_Release.xls ==================================== Search criteria: Venture Capital companies firms investments million billion health medical devices I hope the information provided is helpful! Best regards, Bobbie7

Health Care Investment Visions: Resources::
Contact Us. Resources. HITOutlook Logo. HIT Outlook® is a publication from Health Care Investment Visions that provides analysis, strategy, and provocative
http://www.hciv.com/resources/index.htmlHOME

Cephalon | Investors | Ownership Profile::
Top Holders. Shares Held, % O/S, Share Change, Filing Date State Street Global Advisors (US), 1824448, 2.7, 290333, 09/30/08
http://www.cephalon.com/investors/ownership-profile/HOME